G1 Therapeutics (GTHX) stock forecast for 2026

The forecast has been updated: August 7, 2022 12:23


G1 Therapeutics stock price online today

Analyst Target Price

38.17

Dividend Date

-

Ex Dividend Date

-

Last Split Factor

Last Split Date

01.01.1970

Should you buy or sell G1 Therapeutics stock stock today? What is the projected target price level for 2026? How much will it cost in 2026? G1 Therapeutics stock Stock Monthly Prediction for January, February, March, April, May, July, July, August, September, October, November and December 2026.

We predict the dynamics of the stock market value using resonant artificial intelligence systems.

Technical, fundamental analyzes, news background, general geopolitical situation in the world and other factors are taken into account.

Forecasts are adjusted once a day taking into account the price change of the previous day.

To date, analysts have a $38.17 target price for G1 Therapeutics stock stock.

Today 200 Day Moving Average is the support level (8.9 $).

50 Day Moving Average is the support level (6.15 $).




GTHX Forecast for 2026

Month Rate Forecast MIN Rate MAX Rate Volati-
lity, %
Jan 47.45 42.59 57.19 25.54 %
Feb 53.22 46.61 60.12 22.47 %
Mar 57.39 52.58 63.12 16.69 %
Apr 69.01 59.32 79.63 25.50 %
May 68.82 55.07 76.07 27.60 %
Jun 84.99 76.73 101.51 24.41 %
Jul 90.49 76.57 106.13 27.86 %
Aug 94.16 84.75 99.50 14.82 %
Sep 85.01 71.47 94.88 24.68 %
Oct 87.07 68.74 105.18 34.65 %
Nov 89.89 84.80 107.85 21.38 %
Dec 77.76 70.20 84.06 16.48 %

The forecasts table above shows the forecast values of the company's stock price for each month. The Rate Forecast column displays the Optimal Average Forecast Price. The MIN Rate column displays a pessimistic forecast for this month. “MAX Rate” is an optimistic forecast. The % Volatility column represents the approximate monthly volatility of G1 Therapeutics stock.


G1 Therapeutics overview

G1 Therapeutics Address

79 T.W. ALEXANDER DRIVE, 4501 RESEARCH COMMONS, SUITE 100, RESEARCH TRIANGLE PARK, NC, US

Market Capitalization

556 136 000 $

EBITDA

-161 988 000

PE Ratio

None

PEG Ratio

0

Dividend Per Share

0

Dividend Yield

0

EPS

-4.032

Quarterly Earnings Growth YOY

0

Quarterly Revenue Growth YOY

0.601

Trailing PE

-

Forward PE

-

EV To Revenue

11.26

EV To EBITDA

-1.661

52 Week High

16.65

52 Week Low

3.84

50 Day Moving Average

6.15

200 Day Moving Average

8.9

Shares Outstanding

42746800

Shares Float

Shares Short Prior Month

Short Ratio

Percent Insiders

Percent Institutions

G1 Therapeutics stock forecast for this year


G1 Therapeutics stock forecast for Jan 2026.
Estimated Average Forecasted G1 Therapeutics Price: 47.45. Positive monthly dynamics of the instrument is expected with 25.539% volatility is expected.

Pessimistic forecast: 42.59

Optimistic: 57.19


G1 Therapeutics stock forecast for Feb 2026.
Estimated Average Forecasted G1 Therapeutics Price: 53.22. Positive monthly dynamics of the instrument is expected with 22.468% volatility is expected.

Pessimistic forecast: 46.61

Optimistic: 60.12


G1 Therapeutics stock forecast for Mar 2026.
Estimated Average Forecasted G1 Therapeutics Price: 57.39. Positive monthly dynamics of the instrument is expected with 16.692% volatility is expected.

Pessimistic forecast: 52.58

Optimistic: 63.12


G1 Therapeutics stock forecast for Apr 2026.
Estimated Average Forecasted G1 Therapeutics Price: 69.01. Positive monthly dynamics of the instrument is expected with 25.505% volatility is expected.

Pessimistic forecast: 59.32

Optimistic: 79.63


G1 Therapeutics stock forecast for May 2026.
Estimated Average Forecasted G1 Therapeutics Price: 68.82. Negative monthly dynamics of the instrument is expected with 27.603% volatility is expected.

Pessimistic forecast: 55.07

Optimistic: 76.07


G1 Therapeutics stock forecast for Jun 2026.
Estimated Average Forecasted G1 Therapeutics Price: 84.99. Positive monthly dynamics of the instrument is expected with 24.414% volatility is expected.

Pessimistic forecast: 76.73

Optimistic: 101.51


G1 Therapeutics stock forecast for Jul 2026.
Estimated Average Forecasted G1 Therapeutics Price: 90.49. Positive monthly dynamics of the instrument is expected with 27.857% volatility is expected.

Pessimistic forecast: 76.57

Optimistic: 106.13


G1 Therapeutics stock forecast for Aug 2026.
Estimated Average Forecasted G1 Therapeutics Price: 94.16. Positive monthly dynamics of the instrument is expected with 14.820% volatility is expected.

Pessimistic forecast: 84.75

Optimistic: 99.50


G1 Therapeutics stock forecast for Sep 2026.
Estimated Average Forecasted G1 Therapeutics Price: 85.01. Negative monthly dynamics of the instrument is expected with 24.675% volatility is expected.

Pessimistic forecast: 71.47

Optimistic: 94.88


G1 Therapeutics stock forecast for Oct 2026.
Estimated Average Forecasted G1 Therapeutics Price: 87.07. Positive monthly dynamics of the instrument is expected with 34.647% volatility is expected.

Pessimistic forecast: 68.74

Optimistic: 105.18


G1 Therapeutics stock forecast for Nov 2026.
Estimated Average Forecasted G1 Therapeutics Price: 89.89. Positive monthly dynamics of the instrument is expected with 21.378% volatility is expected.

Pessimistic forecast: 84.80

Optimistic: 107.85


G1 Therapeutics stock forecast for Dec 2026.
Estimated Average Forecasted G1 Therapeutics Price: 77.76. Negative monthly dynamics of the instrument is expected with 16.485% volatility is expected.

Pessimistic forecast: 70.20

Optimistic: 84.06



Other Healthcare sector assets

Name Symbol Last Close Price Change
Abbott Laboratories
ABT 107.91 (09.08.2022) -1.00 %
AbbVie Inc.
ABBV 140.25 (09.08.2022) -0.06 %
Aeterna Zentaris Inc.
AEZS 4.9256 (09.08.2022) -2.46 %
Allakos Inc.
ALLK 3.66 (09.08.2022) -6.15 %
Allogene Therapeutics, Inc.
ALLO 15.03 (09.08.2022) -5.83 %
Amgen Inc.
AMGN 248.36 (09.08.2022) 0.43 %
Aphria Inc.
APHA 15.38 (07.05.2021) 0.00 %
Atara Biotherapeutics, Inc.
ATRA 4.69 (09.08.2022) 29.20 %
Aurora Cannabis Inc.
ACB 1.5 (09.08.2022) -9.09 %
Becton Dickinson and Company
BDX 255.3 (09.08.2022) -0.26 %
Biogen Inc.
BIIB 217.59 (09.08.2022) 0.01 %
Biohaven Pharmaceutical Holding Company Ltd.
BHVN 147.35 (09.08.2022) 0.14 %
BioNTech SE
BNTX 157.21 (09.08.2022) -7.14 %
bluebird bio, Inc.
BLUE 5.5 (09.08.2022) -13.25 %
Boston Scientific Corp.
BSX 40.97 (08.08.2022) 0.07 %
Bristol-Myers Squibb Company
BMY 74.96 (09.08.2022) 1.57 %
Canopy Growth Corp.
CGC 2.87 (09.08.2022) -12.50 %
Castle Biosciences, Inc.
CSTL 30.64 (09.08.2022) 7.58 %
CLOVER HEALTH INVESTMENTS, CORP
CLOV 3.16 (07.01.2022) -5.67 %
Eli Lilly and Company
LLY 242.27 (04.02.2022) 0.00 %
Emergent BioSolutions Inc.
EBS 30.55 (08.08.2022) -3.48 %
Exelixis, Inc.
EXEL 18.56 (17.06.2022) 5.63 %
G1 Therapeutics, Inc.
GTHX 11.79 (09.08.2022) 8.26 %
Gilead Sciences, Inc.
GILD 62 (09.08.2022) 0.65 %
GlaxoSmithKline plc
GSK 40.41 (21.07.2022) 0.00 %
GoodRx Holdings, Inc.
GDRX 7.81 (09.08.2022) 0.64 %
GW Pharmaceuticals plc.
GWPH 218.96 (05.05.2021) 0.00 %
Incyte Corp.
INCY 73.73 (09.08.2022) -0.36 %
Inovio Pharmaceuticals, Inc.
INO 2.1 (09.08.2022) -11.02 %
Johnson & Johnson
JNJ 170.18 (09.08.2022) -0.01 %
Medtronic plc.
MDT 93.1 (09.08.2022) -0.51 %
Merck & Co., Inc.
MRK 89.52 (09.08.2022) 1.16 %
Moderna, Inc.
MRNA 171.14 (09.08.2022) -6.45 %
Novartis AG
NVS 87.15 (09.08.2022) 1.41 %
Novavax, Inc.
NVAX 40.28 (09.08.2022) -29.64 %
ObsEva SA
OBSV 0.305 (09.08.2022) 6.64 %
OrganiGram Holdings Inc.
OGI 1.09 (09.08.2022) -8.40 %
Pfizer Inc.
PFE 49.78 (09.08.2022) 0.42 %
Regeneron Pharmaceuticals, Inc.
REGN 622.15 (09.08.2022) -1.34 %
Sanofi
SNY 48.66 (09.08.2022) -0.86 %
Schrodinger, Inc.
SDGR 31.44 (09.08.2022) -4.18 %
Senseonics Holdings, Inc.
SENS 1.85 (09.08.2022) -5.61 %
Sorrento Therapeutics, Inc.
SRNE 2.59 (09.08.2022) -6.50 %
Stryker Corp.
SYK 214.95 (09.08.2022) -1.09 %
Sundial Growers Inc.
SNDL 2.69 (09.08.2022) -4.27 %
Teva Pharmaceutical Industries Lim. (TEVA)
TEVA 11 (09.08.2022) -0.27 %
Thermo Fisher Scientific Inc.
TMO 580.87 (09.08.2022) -0.53 %
Tilray, Inc.
TLRY 3.84 (09.08.2022) -10.70 %
UnitedHealth Group, Inc.
UNH 537.26 (09.08.2022) 0.12 %
Veeva Systems Inc.
VEEV 222.05 (09.08.2022) -1.60 %
Zomedica Corp.
ZOM 0.3581 (09.08.2022) -6.26 %
Zynerba Pharmaceuticals, Inc.
ZYNE 1.2 (09.08.2022) -4.00 %


Denial of responsibility:

The portal leoprophet.com is not responsible for the loss of your money as a result of your use of the information contained on the site, including data, quotes, charts and forecasts. Operations in the stock, foreign exchange and commodity markets involve a high level of risk, and you are solely responsible for your operations. Only speculate with money that you can afford to lose. All prices and forecasts for stocks, indices, futures are indicative and should not be trade dependent. The portal is not responsible for any losses that you may incur as a result of using this data.